Results: Incidence rates for pancreatitis (adjusted HR [aHR] 9.1, 95% confidence interval [CI] 1.25-66), bowel obstruction (aHR 4.2, 95% CI 1.02-17.4), and gastroparesis (aHR 3.7, 95% CI 1.2-11.9) were significantly higher among users of GLP-1 receptor agonists compared to buproprion-naltrexone users
The most common ones are gastrointestinal which makes sense, since these drugs work partly in the gut
"However, clinical adoption will require safety trials that include bone density monitoring, along with confirmatory data in humans."
It is important to note that these strategies are not at this time FDA-approved to prevent, mitigate, treat, or cure uterine fibroids and should not be confused as such
It comes 100% pure, without additives or preservatives
Please consult a qualified mental health professional for personalized guidance.